Literature DB >> 6703548

Systemic absorption of enteral vancomycin in a patient with pseudomembranous colitis.

P G Spitzer, G M Eliopoulos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6703548     DOI： 10.7326/0003-4819-100-4-533

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  13 in total

1.  A clinical view of vancomycin in 1990.

Authors:  W T Siebert
Journal:  Tex Heart Inst J       Date:  1990

2.  Vancomycin and necrotising enterocolitis.

Authors:  R Tulloh; K Brownlee; P Dear
Journal:  Arch Dis Child       Date:  1986-07       Impact factor: 3.791

3.  A Prospective Pilot Study on the Systemic Absorption of Oral Vancomycin in Children With Colitis.

Authors:  James W Antoon; Margaret Hall; Diana Metropulos; Michael J Steiner; Ravi Jhaveri; Jacob A Lohr
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Sep-Oct

Review 4.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

5.  Systemic absorption of vancomycin.

Authors:  C J Armstrong; T S Wilson
Journal:  J Clin Pathol       Date:  1995-07       Impact factor: 3.411

6.  Oral Absorption of Enteral Vancomycin in a Child with Clostridium difficile Colitis and Renal Impairment.

Authors:  Adam Wood; Katie Wassil; Elisa Edwards
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

7.  Pharmacokinetics of LFF571 and vancomycin in patients with moderate Clostridium difficile infections.

Authors:  Suraj G Bhansali; Kathleen Mullane; Lillian S L Ting; Jennifer A Leeds; Kristina Dabovic; Jens Praestgaard; Peter Pertel
Journal:  Antimicrob Agents Chemother       Date:  2014-12-22       Impact factor: 5.191

Review 8.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

9.  Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection.

Authors:  Milagros Gonzales; Jacques Pepin; Eric H Frost; Julie C Carrier; Stephanie Sirard; Louis-Charles Fortier; Louis Valiquette
Journal:  BMC Infect Dis       Date:  2010-12-30       Impact factor: 3.090

10.  Oral vancomycin hydrochloride therapy for postoperative methicillin-cephem-resistant Staphylococcus aureus enteritis.

Authors:  T Konishi; Y Idezuki; H Kobayashi; K Shimada; S Iwai; K Yamaguchi; N Shinagawa
Journal:  Surg Today       Date:  1997       Impact factor: 2.540
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.